Antibiotice sees slight growth

Drugmaker Antibiotice Iasi has met the targets for 2003: only slight turnover and profit growth, as stronger financial stability was favoured. The company yesterday reported preliminary sales worth $36m (1,215bn ROL), up 5% from 2002. But, in real terms, sales actually dropped because of last year’s 14% inflation rate. The preliminary net profit accounted for $4m (136bn ROL), up from $3.6m in 2002. “The results have met the expectations and our strategy. We have tried to work less with the domestic market and to increase the share of profit in sales,” Ioan Nani, general manager of Antibiotice Iasi, told Ziarul Financiar. ZF